Anti-arrhythmic agents Way 123,398 and E4031 are selective blockers of Kv11.1 have been shown to impart therapeutic benefit in cancer as observed in various in vitro and pre-clinical models of cancer [135,142,143]. Here, KCNH2 is linked to cancer.